foxo4-dri peptide senolytic 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound bpc-157 pharmacokinetics half-life study Packaging::5mg anti-inflammatory drug
Pay in 4 interest-free payments of $7.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12